The Impact of Retail Sector Delivery of Artemether-Lumefantrine on Effective Malaria Treatment of...
-
Upload
harold-harmon -
Category
Documents
-
view
213 -
download
0
Transcript of The Impact of Retail Sector Delivery of Artemether-Lumefantrine on Effective Malaria Treatment of...
The Impact of Retail Sector Delivery of Artemether-Lumefantrine on Effective Malaria Treatment of Children Under Five in Kenya
Sarah V. Kedenge Beth Kangwana; Abdisalan M. Noor; Victor A. Alegana ; Andrew J Nyandigisi ; Jayesh Pandit ; Greg W Fegan ; Simon Brooker; Robert W Snow; Catherine A. Goodman
KEMRI-Wellcome Trust Research Programme
General Study Design • Design: pre-post randomized cluster controlled
trial to compare intervention and control areas
Teso
Butere Mumias
Busia
Survey ActivitiesHousehold and retail censuses, household, provider and
mystery shopper surveys and FGDs
Description of Under 5 Population Surveyed
• 86% of fevers experienced within 2 weeks of the interview had some action taken by caregiver
• Majority of actions were visits made to government facilities (31%) and specialized drug stores (33%)
• Also frequently used were general stores (18%)
Fever treatment actions taken by caregivers
• 3,288 households surveyed at baseline and 3,182 at follow up
• Total Under 5 population surveyed was 2,749 and 2,662 at baseline and follow up respectively
•Fever prevalence in children 3-59 months (in past 2 weeks) averaged at 28% at baseline and 30% at follow up
Anti-malarials Received
ControlMean (SD )
InterventionMean (SD )
P valueUnadjustedAdjusted
Baseline 39% (7.8) 46% (9.4)
Follow up 50%(11.8) 64%(10.5) 0.01920.0074
ControlMean (SD )
InterventionMean (SD )
P valueUnadjustedAdjusted
Baseline 30% (11.1) 39% (7.7)
Follow up 23% (7.8) 12% (4.8) 0.00360.0518
RECEIVED AN ANTI MALARIAL
RECEIVED AN ANTI- MALARIAL MONOTHERAPY
Children 3-59 months who received AL on the same day or following day of fever developing
CONTROL INTERVENTION0%
10%
20%
30%
40%
50%
60%
70%
80%
5% 5%
20%
45%
BASELINE
FOLLOW UP
P-value= 0.0001
Adherence
ControlMean (SD )
InterventionMean (SD )
P valueUnadjustedAdjusted
Baseline 40% (23.3) 53% (40.2)
Follow up 49% (24.8) 67% (8.5) 0.06060.1095
ADHERED TO THE RIGHT DOSE
ADHERED TO THE RIGHT PRICE
• 95% of those purchasing Tibamal reported paying the recommended retail price of 20KSH ($0.25)
Study Limitations
• Distribution of AL
• Study limited to children 3-59 months
• Studies limited to one province which is malaria endemic and at the Kenyan-Ugandan border
• Difficult to determine future changes in treatment seeking behavior
Policy Implications & Lessons learnt• Subsidizing ACTs in the retail sector can lead to a
substantial increase in coverage in prompt and effective treatment
• Although the design of the intervention differs with that of AMF-m, the findings can be cautiously interpreted to demonstrate how crowding out anti-malarial monotherapies and increasing access to AL by increasing its distribution at decreased costs could work
• Further research required to:- assess feasibility of introducing diagnosis at retail outlets to improve targeting of ACT.- come up with innovative and practical strategies to improve drug adherence both in the public and private sector.
Acknowledgements
• Division of Malaria Control: Dr Juma, Dr Akhwale, Dr Memusi, Dr Nyandigisi and the team
• Pharmacy and Poisons Board: Dr Pandit• Population Services International : Manya
Andrews and Mbogo Bunyi and the rest of the team
• DFID, USAID and the Wellcome Trust• DHMTs and DOs in Teso, Butere Mumias and
Busia• Field workers, shopkeepers and care givers